Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 3.77
(3.86%)
CNY 3.77
(3.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.53 Million CNY | 41.76% |
| 2022 | 1.08 Million CNY | -98.93% |
| 2021 | 101.21 Million CNY | 339635252861337500.0% |
| 2020 | - CNY | -100.0% |
| 2019 | 283.74 Million CNY | -2.9% |
| 2018 | 292.21 Million CNY | 46.4% |
| 2017 | 199.6 Million CNY | 411.15% |
| 2016 | 39.04 Million CNY | -34.68% |
| 2015 | 59.78 Million CNY | 144.01% |
| 2014 | 24.5 Million CNY | 19.51% |
| 2013 | 20.5 Million CNY | 41.38% |
| 2012 | 14.5 Million CNY | 31.82% |
| 2011 | 11 Million CNY | 69.23% |
| 2010 | 6.5 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 4.65 Million CNY | 0.0% |
| 2007 | 4.65 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 985.33 Thousand CNY | 0.0% |
| 2024 Q2 | 969.79 Thousand CNY | 0.0% |
| 2024 Q3 | 969.79 Thousand CNY | 0.0% |
| 2023 FY | 1.53 Million CNY | 41.76% |
| 2023 Q1 | 1.76 Million CNY | 62.93% |
| 2023 Q4 | 1.53 Million CNY | -20.05% |
| 2023 Q2 | 1.88 Million CNY | 6.78% |
| 2023 Q3 | 1.91 Million CNY | 1.92% |
| 2022 Q3 | 962.05 Thousand CNY | -99.02% |
| 2022 Q2 | 97.82 Million CNY | -3.53% |
| 2022 Q1 | 101.39 Million CNY | 0.17% |
| 2022 FY | 1.08 Million CNY | -98.93% |
| 2022 Q4 | 1.08 Million CNY | 12.35% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q3 | 474.94 Thousand CNY | -97.73% |
| 2021 FY | 101.21 Million CNY | 339635252861337500.0% |
| 2021 Q4 | 101.21 Million CNY | 21212.0% |
| 2021 Q2 | 20.94 Million CNY | 0.0% |
| 2020 Q3 | 229.95 Million CNY | -1.79% |
| 2020 Q1 | 263.95 Million CNY | -6.97% |
| 2020 FY | - CNY | -100.0% |
| 2020 Q2 | 234.14 Million CNY | -11.29% |
| 2020 Q4 | 32.77 Million CNY | -85.75% |
| 2019 Q1 | 293.25 Million CNY | 0.36% |
| 2019 FY | 283.74 Million CNY | -2.9% |
| 2019 Q4 | 283.74 Million CNY | -3.83% |
| 2019 Q3 | 295.04 Million CNY | -1.61% |
| 2019 Q2 | 299.87 Million CNY | 2.26% |
| 2018 Q1 | 204.75 Million CNY | 2.58% |
| 2018 Q3 | 284.54 Million CNY | 31.01% |
| 2018 FY | 292.21 Million CNY | 46.4% |
| 2018 Q2 | 217.2 Million CNY | 6.08% |
| 2018 Q4 | 292.21 Million CNY | 2.7% |
| 2017 Q3 | 10.61 Million CNY | -46.43% |
| 2017 Q2 | 19.81 Million CNY | -61.47% |
| 2017 Q1 | 51.43 Million CNY | 31.73% |
| 2017 Q4 | 199.6 Million CNY | 1779.95% |
| 2017 FY | 199.6 Million CNY | 411.15% |
| 2016 FY | 39.04 Million CNY | -34.68% |
| 2016 Q3 | 53.24 Million CNY | -37.2% |
| 2016 Q4 | 39.04 Million CNY | -26.66% |
| 2016 Q1 | 112.32 Million CNY | 87.89% |
| 2016 Q2 | 84.78 Million CNY | -24.52% |
| 2015 Q2 | 46.25 Million CNY | 88.78% |
| 2015 Q4 | 59.78 Million CNY | -15.02% |
| 2015 FY | 59.78 Million CNY | 144.01% |
| 2015 Q1 | 24.5 Million CNY | 0.0% |
| 2015 Q3 | 70.34 Million CNY | 52.1% |
| 2014 Q1 | 20.5 Million CNY | 0.0% |
| 2014 FY | 24.5 Million CNY | 19.51% |
| 2014 Q4 | 24.5 Million CNY | 6.52% |
| 2014 Q3 | 23 Million CNY | 6.98% |
| 2014 Q2 | 21.5 Million CNY | 4.88% |
| 2013 Q2 | 14.5 Million CNY | 0.0% |
| 2013 Q4 | 20.5 Million CNY | 41.38% |
| 2013 Q3 | 14.5 Million CNY | 0.0% |
| 2013 Q1 | 14.5 Million CNY | 0.0% |
| 2013 FY | 20.5 Million CNY | 41.38% |
| 2012 Q3 | 14.5 Million CNY | 0.0% |
| 2012 FY | 14.5 Million CNY | 31.82% |
| 2012 Q1 | 11 Million CNY | 0.0% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q4 | 14.5 Million CNY | 0.0% |
| 2011 Q3 | 6.5 Million CNY | 0.0% |
| 2011 FY | 11 Million CNY | 69.23% |
| 2011 Q1 | 6.5 Million CNY | 0.0% |
| 2011 Q2 | 6.5 Million CNY | 0.0% |
| 2011 Q4 | 11 Million CNY | 69.23% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q4 | 6.5 Million CNY | 0.0% |
| 2010 FY | 6.5 Million CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2008 FY | 4.65 Million CNY | 0.0% |
| 2007 FY | 4.65 Million CNY | 0.0% |